DFDA

Doppler-guided Hemorrhoidal Artery Ligation (DG-HAL)

Treatment for Hemorrhoids

Typical Dosage: Surgical procedure

Effectiveness
78%
Safety Score
60%
Clinical Trials
1
Participants
15K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
Surgical procedure
Time to Effect
Weeks to months for full symptom improvement
Treatment Duration
Single procedure, recovery days to a week
Evidence Quality
MODERATE
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$300
Side Effect Mgmt:$200
Total Annual:$4,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$10,000/QALY
QALYs Gained
0.4
Outcome-Based Costs
Cost per Responder
$5,479
Cost per Remission
$7,273
Doppler-guided Hemorrhoidal Artery Ligation (DG-HAL) Outcomes

for Hemorrhoids

Efficacy Outcomes
Overall Effectiveness
+78%
Response Rate
+73%
Remission Rate
+55%
Common Side Effects
Post-operative pain
+30%
Tenesmus
+7%
Bleeding
+3%
Recurrence
+15%

Sources:

nih.gov
nih.gov
e-century.us

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Doppler-guided Hemorrhoidal Artery Ligation (DG-HAL) in Hemorrhoids

Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease

NCT05697562RECRUITINGNA
View Study
80 participants
INTERVENTIONAL
Jette, Belgium
Started: Jun 1, 2023